BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Pfizer Inc. (PFE)'s Wyeth (WYE) Unit Seeks $960 Million in Damages From Sun Pharmaceutical Industries Ltd


2/16/2012 7:45:12 AM

Sun Pharmaceutical Industries Ltd., the most profitable generic drugmaker, headed for its biggest drop in about three months after Pfizer Inc.’s Wyeth unit filed a suit claiming $960 million in damages from the Indian company. Sun fell 2.8 percent to 541.15 rupees, poised for its steepest fall since Nov. 16, after declining as much as 3.9 percent at 11:40 a.m. in Mumbai. The stock was the biggest loser in the 19-company BSE Healthcare Index. Sun and Teva Pharmaceutical Industries Ltd. began selling copies of Wyeth’s anti-acidity medicine before a patent dispute could be resolved. The Mumbai-based company sold the drug from Jan. 2008 till it was ordered to stop sales by a U.S. federal court in April 2010. Wyeth’s court filing this week includes sales lost due to Sun’s entry in the market, litigation costs and other damages relating to Protonix, said Souvik Chatterjee, an analyst at SMC Global Securities Ltd.

Read at BusinessWeek
Read at Wall Street Journal
Read at Money Control
Read at India Times
Read at PharmaBiz

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->